Pluri Inc. Teams Up with Wilk to Scale Up Human Breast Milk-Based Medical Food for Seniors

In an innovative step towards transforming elderly nutrition, Pluri Inc. PLUR, a pioneer in 3D cell expansion technology, has announced its collaboration with Wilk to heighten the production of human breast milk-derived food products. This joint venture aims to harness the complex nutritional profile of human breast milk to create medical food solutions targeted at improving the health of the elderly population.

Advancing Elderly Nutrition Through Cutting-Edge Science

At the core of this collaboration is the intent to revolutionize senior care dietary options by developing a new production process that leverages Pluri's proprietary technology. Human breast milk oligosaccharides have been recognized for their role in shaping the gut microbiota, which in turn provides significant health benefits — benefits that Pluri and Wilk are determined to make accessible to adults in a more scalable and sustainable way.

Capitalizing on Human Milk Oligosaccharides for Gut Health

The potential that lies within human breast milk oligosaccharides is phenomenal, and through the expertise of Pluri Inc. PLUR, an advanced production process will be formulated. This process aims to replicate the nurturing effects of these oligosaccharides, which are known to foster a healthy gut microbiota, ultimately contributing to better health outcomes for the elderly.

Expanding Commercial Ventures in Health Nutrition

In the quest to uplift the standard of senior nutrition, Pluri's cutting-edge 3D cell expansion technology presents a potent instrument. Merging biotechnological advancements with the rich, beneficial properties of human breast milk represents a new horizon in medical foods, promising an enhanced quality of life for the aging population. Pluri Inc. PLUR is at the forefront of this transformation, pioneering the expansion of these high-potential solutions to the commercial marketplace.

Nutrition, Technology, Health